Pharmacoeconomics:
The Ph.D. program in health outcomes and policy research, with a concentration in pharmacoeconomics, is designed to develop the knowledge and skills necessary
for evaluation of the economic, clinical and humanistic outcomes of medical
treatment. The Program focuses on producing graduates for positions that focus
on research, and less on positions that are administrative, such as hospital
administration.
Topics addressed in the program include the many facets of economics in
healthcare, including the use of pharmaceuticals, appropriateness and quality of
care, patient outcomes, patient satisfaction with care, costs of both
appropriate and inappropriate medication use, public policies related to health
care and pharmacoepidemiological considerations. The course of study examines
the respective roles and behaviors of the healthcare professionals (e.g.,
physicians, pharmacists, nurses, allied health) involved in patient care and the
influence of healthcare-related organizations (e.g., managed care, health
maintenance organizations, public and private insurance, pharmaceutical
manufacturers) on health outcomes. Very important to the medication use process
and the understanding of health disparities is the
role of the patient.
Program Director: Shelley I. White-Means
|
